1. The Relationship Between Clinical Benefit and Receipt of Curative Therapy for Prostate Cancer
- Author
-
Danil V. Makarov, Jessica B. Long, Cary P. Gross, Ann C. Raldow, Richa Sharma, Laura D. Cramer, James B. Yu, Pamela R. Soulos, and Carolyn J Presley
- Subjects
Male ,medicine.medical_specialty ,Risk Assessment ,Article ,Prostate cancer ,Life Expectancy ,Early Medical Intervention ,Outcome Assessment, Health Care ,Internal Medicine ,medicine ,Humans ,Veterans Affairs ,Aged ,Neoplasm Staging ,Aged, 80 and over ,Prostatectomy ,Gynecology ,Receipt ,Radiotherapy ,business.industry ,Prostatic Neoplasms ,medicine.disease ,Therapeutic Radiology ,Survival Rate ,Family medicine ,Practice Guidelines as Topic ,Neoplasm staging ,Quality-Adjusted Life Years ,Neoplasm Grading ,business - Abstract
Ann C. Raldow, MD1,2, Carolyn J. Presley, MD1,3, James B. Yu, MD1,4, Richa Sharma, MPH1, Laura D. Cramer, PhD1, Pamela R. Soulos, MPH1,3, Jessica B. Long, MPH1,3, Danil V. Makarov, MD, MHS1,5, and Cary P. Gross, MD1,3 1Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Comprehensive Cancer Center and Yale University School of Medicine 2Department of Medicine, Memorial Sloan Kettering Cancer Center 3Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine 4Department of Therapeutic Radiology, Yale University School of Medicine 5Department of Urology, New York University School of Medicine and United States, Department of Veterans Affairs
- Published
- 2012
- Full Text
- View/download PDF